0001493152-24-011215.txt : 20240325 0001493152-24-011215.hdr.sgml : 20240325 20240325213011 ACCESSION NUMBER: 0001493152-24-011215 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240321 FILED AS OF DATE: 20240325 DATE AS OF CHANGE: 20240325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alder Matthias CENTRAL INDEX KEY: 0001370820 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40237 FILM NUMBER: 24780773 MAIL ADDRESS: STREET 1: C/O MICROMET, INC. STREET 2: 6707 DEMOCRACY BLVD., STE. 505 CITY: BETHESDA STATE: MD ZIP: 28017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gain Therapeutics, Inc. CENTRAL INDEX KEY: 0001819411 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851726310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: (301) 500-1556 MAIL ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 ownership.xml X0508 4 2024-03-21 0 0001819411 Gain Therapeutics, Inc. GANX 0001370820 Alder Matthias C/O GAIN THERAPEUTICS, INC. 4800 MONTGOMERY LANE, SUITE 220 BETHESDA MD 20814 1 1 0 0 Chief Executive Officer 0 Employee Stock Option (right to buy) 4.37 2024-03-21 4 A 0 370000 0.00 A 2034-03-21 Common Stock 370000 370000 D The shares underlying the option shall vest 25% on March 21, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. /s/ Matthias Alder 2024-03-25